Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU627540B2 - Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof - Google Patents
[go: Go Back, main page]

AU627540B2 - Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof - Google Patents

Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof

Info

Publication number
AU627540B2
AU627540B2 AU48062/90A AU4806290A AU627540B2 AU 627540 B2 AU627540 B2 AU 627540B2 AU 48062/90 A AU48062/90 A AU 48062/90A AU 4806290 A AU4806290 A AU 4806290A AU 627540 B2 AU627540 B2 AU 627540B2
Authority
AU
Australia
Prior art keywords
hiv
preparation
drug
infection
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU48062/90A
Other versions
AU4806290A (en
Inventor
Michel Grandgeorge
Francois Pelloquin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Pasteur Merieux Serum et Vaccines SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serum et Vaccines SA filed Critical Pasteur Merieux Serum et Vaccines SA
Publication of AU4806290A publication Critical patent/AU4806290A/en
Application granted granted Critical
Publication of AU627540B2 publication Critical patent/AU627540B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Drug for the treatment or prevention by passive immunization of the HIV-infection and processes for preparation thereof. According to the invention, the drug consists of, or comprises, a preparation of anti-HIV gammaglobulins Ig6 and/or IgM of human origin without antibodies directed against glycoproteins of the HIV virus envelope and/or anti-CD4 antibodies.
AU48062/90A 1988-12-15 1989-12-15 Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof Ceased AU627540B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8816580 1988-12-15
FR8816580A FR2640511B1 (en) 1988-12-15 1988-12-15 MEDICINES FOR THE TREATMENT OR PREVENTION BY PASSIVE IMMUNIZATION OF HIV VIRUS INFECTION AND METHOD OF PREPARATION

Publications (2)

Publication Number Publication Date
AU4806290A AU4806290A (en) 1990-07-10
AU627540B2 true AU627540B2 (en) 1992-08-27

Family

ID=9373004

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48062/90A Ceased AU627540B2 (en) 1988-12-15 1989-12-15 Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof

Country Status (13)

Country Link
EP (1) EP0374053B1 (en)
JP (1) JPH03505738A (en)
CN (1) CN1045035A (en)
AT (1) ATE102836T1 (en)
AU (1) AU627540B2 (en)
CA (1) CA2005365C (en)
DE (1) DE68913932T2 (en)
DK (1) DK192990D0 (en)
ES (1) ES2062079T3 (en)
FR (1) FR2640511B1 (en)
IE (1) IE63831B1 (en)
WO (1) WO1990006773A1 (en)
ZA (1) ZA899533B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0686260B1 (en) * 1993-02-05 2003-07-09 Epigen, Inc. Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
CN106110422B (en) * 2016-07-01 2019-02-01 翁炳焕 AIDS immunization therapy absorber

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3604947A1 (en) * 1986-02-17 1987-08-20 Biotest Pharma Gmbh METHOD FOR PRODUCING AN IMMUNALLOBULIN-CONTAINING PREPARATE AND THE USE THEREOF FOR PROPHYLAXIS AND THERAPY OF AIDS
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
AU618555B2 (en) * 1987-08-11 1992-01-02 Biomune Corporation Hyper-immune globulin against hiv

Also Published As

Publication number Publication date
EP0374053B1 (en) 1994-03-16
ES2062079T3 (en) 1994-12-16
JPH03505738A (en) 1991-12-12
FR2640511B1 (en) 1993-04-23
CN1045035A (en) 1990-09-05
ATE102836T1 (en) 1994-04-15
WO1990006773A1 (en) 1990-06-28
DE68913932D1 (en) 1994-04-21
DE68913932T2 (en) 1994-07-07
FR2640511A1 (en) 1990-06-22
EP0374053A1 (en) 1990-06-20
IE894005L (en) 1990-06-15
CA2005365A1 (en) 1990-06-15
ZA899533B (en) 1990-12-28
AU4806290A (en) 1990-07-10
CA2005365C (en) 1995-12-12
IE63831B1 (en) 1995-06-14
DK192990A (en) 1990-08-14
DK192990D0 (en) 1990-08-14

Similar Documents

Publication Publication Date Title
AUPO784197A0 (en) Treatment of nasopharyngeal carcinoma
EP0429477A4 (en) Synthetic vaccine against aids virus
EP0724651A4 (en) SYNTHETIC HUMAN MONOCLONAL ANTIBODIES DIRECTED AGAINST AND NEUTRALIZING THE IMMUNODEFICIENCY VIRUS
CA2192512A1 (en) Nm03 antibody materials and methods
AU4985496A (en) Administration of a cyclosporine-specific monoclonal antibody that cross-reacts with hiv-1 p24 gag to treat hiv infection
DE3479583D1 (en) High titer cytomegalovirus human immune serum globulin and method of making same
EP0687182A4 (en) Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
FI944561L (en) HIV-neutralizing recombinant human monoclonal antibodies for the prevention and treatment of HIV infection
AU8010791A (en) Hiv monoclonal antibody
AU2456888A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
AU627540B2 (en) Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof
DK1438970T3 (en) Method of Inhibiting HIV-Associated Diseases by Monoclonal Antibodies to Self-Targeted Cytotoxic Cells
AU1715292A (en) Human immunodeficiency virus-related immune preparation
EP0323157A3 (en) Antiviral compounds and methods
AU5061090A (en) Aids therapy
CA2160696A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
AU651113B2 (en) HIV GP120 monoclonal antibodies
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
WO1993014760A3 (en) Methods
EP0624372A3 (en) Medicament for treating human immunodeficiency virus.